Release 4B 5

This page is part of the FHIR Specification (v4.3.0: R4B (v5.0.0: R5 - STU ). The This is the current published version which supercedes in it's permanent home (it will always be available at this version is 5.0.0 . URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R5 R4B R4

Using Codes Code Systems Value Sets Concept Maps Identifier Systems

4.3.14.414 4.3.2.318 Code System http://terminology.hl7.org/CodeSystem/research-study-phase CodeSystem http://hl7.org/fhir/research-study-phase

Biomedical Research and Regulation icon Work Group   Maturity Level : 1 0 Draft Trial Use Use Context : Any Country: World
This is a code system defined by the FHIR project.
    Summary
  • Narrative Defining URL:
    • http://terminology.hl7.org/CodeSystem/research-study-phase
  • XML Version:
    • 4.3.0
  • JSON Name:
    • ResearchStudyPhase
  • TTL
Committee:
Official URL : Title: http://hl7.org/fhir/research-study-phase ResearchStudyPhase Definition: Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation. Version : 5.0.0
active as of 2022-05-15 Biomedical Research and Regulation Computable Name : ResearchStudyPhase Work Group
OID: 2.16.840.1.113883.4.642.4.1247 (for OID based terminology systems) Flags : CaseSensitive, Complete. All codes ValueSet: Research Study Phase Source Resource XML / JSON OID : TBD

This Code system is used in the following value sets:

  • ValueSet: ResearchStudyPhase (Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.) ValueSet: ResearchStudyPhase Research Study Phase (Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.)
4.3.14.414.1 Content

4.3.14.414.2 4.3.2.318.1 ResearchStudyPhase Definition

Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.

4.3.2.318.2 Content

This code system http://terminology.hl7.org/CodeSystem/research-study-phase http://hl7.org/fhir/research-study-phase defines the following codes:

Code Display Definition Copy
n-a N/A Trials without phases (for example, studies of devices or behavioral interventions). btn   btn
early-phase-1 Early Phase 1 Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0. btn   btn
phase-1 Phase 1 Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients. btn   btn
phase-1-phase-2 Phase 1/Phase 2 Trials that are a combination of phases 1 and 2. btn   btn
phase-2 Phase 2 Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks. btn   btn
phase-2-phase-3 Phase 2/Phase 3 Trials that are a combination of phases 2 and 3. btn   btn
phase-3 Phase 3 Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug. btn   btn
phase-4 Phase 4 Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use. btn   btn

 

See the full registry of code systems defined as part of FHIR.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. See Code System for further information.
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code